In week 42, there were early increases in seasonal influenza activity, particularly in the southeast and south-central areas of the country.
The predominant viruses reported were influenza A(H3N2).
Outpatient respiratory illness visits were above the national baseline, with 3.3% of visits attributed to respiratory illness that included fever plus a cough or sore throat.
Outpatient illness activity varied by region, with some regions reporting high or very high activity and others reporting minimal or low activity.
Among long-term care facilities, 0.5% reported at least one influenza-positive test among residents.
FluSurv-NET reported a total of 443 laboratory-confirmed influenza-associated hospitalizations, primarily associated with influenza A viruses.
The cumulative hospitalization rate was higher than previous seasons for the same period, with higher rates among older and younger age groups.
Pneumonia, influenza, and COVID-19 mortality accounted for 9.2% of deaths during the week, above the epidemic threshold.
One influenza-associated pediatric death was reported during week 42.
CDC emphasizes the importance of annual influenza vaccination for prevention and the use of antiviral drugs for treatment.
Virologic surveillance showed increasing influenza activity, with a higher percentage of positive specimens reported in clinical and public health laboratories. Genetic and antigenic characterization of the viruses is ongoing.